Larry Altstiel

Larry Altstiel
Dr Larry Altstiel is chief medical officer of ProMIS Neurosciences and has decades of medical expertise in neurodegenerative diseases and experience in the pharmaceutical industry. As the former vice president and head of neuroscience clinical research at Pfizer, Larry led the selection of drug candidates, development and oversight of multiple studies focused on Alzheimer’s Disease.
Dr Larry Altstiel is chief medical officer of ProMIS Neurosciences and has decades of medical expertise in neurodegenerative diseases and experience in the pharmaceutical industry. As the former vice president and head of neuroscience clinical research at Pfizer, Larry led the selection of drug candidates, development and oversight of multiple studies focused on Alzheimer’s Disease.

Articles: Larry Altstiel

Alzheimer’s Immunotherapies: Are We There Yet?

Canada / Drs Neil Cashman and Larry Altstiel of ProMIS Neurosciences weigh in on recent progress towards an effective therapy for Alzheimer’s disease, potentially representing a break from three decades of scientific stagnation.   Are we there yet with Alzheimer’s immunotherapies? No. But we have a map, and it’s a good one.   In late September 2022,…

See more